UPDATED Aug 25, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
THQM | лв17.10 | 1.2% | 2.7% | лв1.6b | n/a | PE253.5x | n/a | 0% | ||
1762 | NT$27.80 | 0.9% | -39.0% | NT$2.1b | n/a | PS1.8x | n/a | 0.7% | ||
766 | CN¥24.64 | 0.08% | 84.8% | CN¥23.8b | n/a | PE391.9x | n/a | n/a | ||
790 | CN¥4.21 | 0.7% | 24.2% | CN¥2.6b | n/a | PS3.2x | n/a | 0% | ||
4570 | JP¥479.00 | 0.4% | -0.6% | JP¥4.5b | n/a | PE17.3x | n/a | 1.3% | ||
ACB | CA$7.25 | 4.8% | -16.9% | CA$390.7m | CA$7.93 | PS1.1x | E121.9% | n/a | ||
MTLF | ₪4.08 | 27.1% | 11.2% | ₪68.3m | n/a | PB8.2x | n/a | n/a | ||
6564 | NT$17.00 | 1.5% | -50.7% | NT$1.2b | n/a | PS29x | n/a | n/a | ||
4195 | NT$24.70 | 1.0% | 27.3% | NT$1.8b | n/a | PS3.2x | n/a | 0% | ||
NYKD | NOK 1.80 | 3.0% | -71.0% | NOK 587.8m | NOK 8.50 | PS7x | E1.1% | 53.9% | ||
CHOSA | SEK 0.53 | 51.4% | -59.2% | SEK 34.4m | n/a | PB2x | n/a | n/a | ||
ALZ | SEK 1.59 | 10.6% | -63.2% | SEK 165.9m | SEK 4.35 | PS6.4x | E-41.0% | n/a | ||
300254 | CN¥12.05 | 0.6% | 51.4% | CN¥3.0b | n/a | PE87.2x | n/a | 0% | ||
2365 | CN¥19.97 | 0.3% | 186.9% | CN¥5.8b | n/a | PE201.1x | n/a | 0.5% | ||
600381 | CN¥4.58 | 0.7% | 49.7% | CN¥2.6b | n/a | PS9.7x | n/a | n/a | ||
300878 | CN¥22.70 | 0.5% | 55.3% | CN¥3.2b | n/a | PS14.6x | n/a | 0.6% | ||
EMGE | US$0.0002 | 19,900.0% | -85.7% | US$85.4k | n/a | n/a | n/a | n/a | ||
CYDY | US$0.31 | 4.4% | 145.1% | US$372.4m | n/a | PE171.8x | n/a | n/a | ||
300434 | CN¥10.74 | 0.4% | 49.6% | CN¥4.3b | n/a | PE66.6x | n/a | 0.6% | ||
603590 | CN¥52.95 | 0.2% | 133.0% | CN¥8.4b | CN¥44.00 | PE187.1x | E40.1% | 1.1% | ||
300313 | CN¥8.78 | 0.6% | 43.2% | CN¥2.7b | n/a | PS19x | n/a | 0% | ||
IDIA | CHF 2.77 | 2.8% | 18.9% | CHF 564.3m | CHF 2.00 | PS2.6x | E45.1% | n/a | ||
TYRA | US$12.00 | 2.5% | -46.2% | US$624.1m | US$30.14 | PB2.1x | E-0.9% | n/a | ||
ZHCL.F | US$0.10 | 100.0% | -23.1% | US$15.4m | n/a | PE-2.2x | n/a | n/a |